ADC from AbbVie's ImmunoGen takeout wins FDA approval for rare blood cancer - FirstWord Pharma
FirstWord Pharma reports on ADC from AbbVie's ImmunoGen takeout wins FDA approval for rare blood cancer in Science & Health.
Take A Coffee NEWS Staff··2 min read
FirstWord Pharma reported ADC from AbbVie's ImmunoGen takeout wins FDA approval for rare blood cancer. Take A Coffee NEWS is tracking the story on the Science & Health desk for readers following medicine, public health, research, climate, space, and science policy.
Source
Why it matters
The story belongs in this desk because it may affect readers tracking medicine, public health, research, climate, space, and science policy.